HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 48, 46785-46790, November 29, 2002

This Article Abstract Full Text (PDF) All Versions of this Article: 277/48/46785    most recent M208068200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ikonomov, O. C. Articles by Shisheva, A. Search for Related Content PubMed PubMed Citation Articles by Ikonomov, O. C. Articles by Shisheva, A. Social Bookmarking                      What's this?

PIKfyve Kinase and SKD1 AAA ATPase Define Distinct Endocytic Compartments

ONLY PIKfyve EXPRESSION INHIBITS THE CELL-VACUOLATING ACTIVITY OF HELICOBACTER PYLORI VacA TOXIN^*

Ognian C. Ikonomov, Diego Sbrissa, Tamotsu Yoshimori^§, Timothy L. Cover^¶, and Assia Shisheva

From the  Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan 48201, the ^§ Department of Cell Genetics, National Institute of Genetics, Yata 1111 Mishima, Shizuoka-ken, Japan, and the ^¶ Department of Medicine and Department of Microbiology and Immunology, Vanderbilt University School of Medicine and Veterans Affairs Medical Center, Nashville, Tennessee 37232

Received for publication, June 21, 2002, and in revised form, August 7, 2002

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

The mammalian phosphatidylinositol (PtdIns)- 5-P/PtdIns-3,5-P₂-producing kinase PIKfyve and AAA ATPase SKD1, as their yeast counterparts, are implicated in the formation and function of multivesicular bodies/late endosomes. Point mutations inhibiting the enzyme activities convert PIKfyve and SKD1 into dominant-negative mutants (PIKfyve^K1831E and SKD1^E235Q), whose expression in cells of kidney origin induces a vacuolation phenotype. This phenotype closely resembles the changes in late endosomal-lysosomal morphology that occur following cell exposure to the vacuolating cytotoxin (VacA) from Helicobacter pylori. Here we have examined the possible functional relationship between PIKfyve and SKD1 as well as the role of these enzymes in the molecular mechanism of VacA-induced intracellular vacuolation. When co-expressed in COS cells, PIKfyve^WT reduced SKD1^E235Qdependent vacuole formation, whereas SKD1^WT did not alter the vacuolation induced by PIKfyve^K1831E. In addition, SKD1^E235Q disrupted the normal distribution of PIKfyve^WT. Expression of PIKfyve^WT in COS and HEK293 cells inhibited vacuolation induced by subsequent intoxication with VacA, and microinjection of the PIKfyve lipid product PtdIns-3,5-P₂ produced a similar inhibitory effect. In contrast, in COS cells expressing SKD1^WT, VacA induced the formation of characteristic vacuoles with an efficiency similar to that in the control cells. These observations demonstrate that, although PIKfyve and SKD1 are functionally related, only PIKfyve regulates VacA action, and suggest that the inhibition of PIKfyve PtdIns-3,5-P₂-producing activity is a key molecular event in VacA-induced cellular vacuolation.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

Despite considerable clinical and basic research efforts, an understanding of the molecular mechanisms whereby the Gram-negative bacterium Helicobacter pylori induces gastritis and peptic ulcers in humans is still elusive. Most H. pylori strains secrete a cytotoxin, VacA, which causes extensive vacuolation in epithelial cells (for a recent review, see Ref. 1). VacA-induced vacuoles represent an aberrant intracellular hybrid compartment that forms as a result of a heterotypic fusion between late endosomes and lysosomes (2, 3). Little is known about the intracellular mechanisms that control VacA-induced reorganization of the late endosomal compartment. A role for several proteins involved in membrane trafficking, such as Rab7, Rac1, and dynamin, has recently been proposed (4-6). However, since none of these proteins nor their loss- or gain-of-function mutants mimic the VacA phenotype (4-6), other proteins and mechanisms relevant to late endosomal compartment biogenesis and function are likely to be involved.

While the broad outline of the membrane traffic through the endocytic pathway from the plasma membrane to the late endosome fusion with the lysosomes (or vacuoles in yeast) is now well established, the molecular mechanism(s) underlying the formation and sorting functions of the late endosomal compartment are poorly understood (for recent reviews, see Refs. 7 and 8). Morphologically, late endosomes appear to contain multiple small vesicles, which originate by invagination and pinching off from the limiting membrane into the lumenal space. Because of this multivesicular appearance, late endosomes have also been referred to as multivesicular bodies (MVBs)¹; both terms are used herein interchangeably. Genetic studies in budding yeast have identified a set of genes, the class E VPS, that are essential in MVB formation (9). Electron microscopy studies of class E vps yeast mutants have documented the presence of an enlarged, aberrant endosomal compartment comprised of stacked membranes (9). A central role among the class E proteins is assigned to Vps4p, an AAA ATPase, whose on/off membrane cycle coupled with ATP hydrolysis regulates the membrane association of other class E proteins (10). A regulatory role in MVB formation is also attributed to Fab1p lipid kinase and its product PtdIns-3,5-P₂. Yeast cells that lack Fab1p function contain abnormally large vacuoles and, like the class E mutant strains, appear to be defective in the formation of MVBs (7, 9). Thus, genetic studies in yeast strongly suggest that the ability to properly invaginate endosomal membranes and to form MVBs is largely dependent on the correct function of Fab1 and Vps4 gene products.

The structural and functional counterparts of yeast Vps4 and Fab1p in mammalian cells are the AAA ATPase SKD1 and the PI 5-/protein kinase PIKfyve, respectively (11, 12). Mutations in their catalytic domains convert these proteins into dominant-negative mutants. Similar to the morphological changes observed in yeast, expression of ATPase-deficient SKD1^E235Q or kinase-deficient PIKfyve^K1831E in mammalian cells of kidney origin induces peripheral vacuoles and enlarged vesicles (13-16). This phenotype is highly reminiscent of the cellular alterations induced by H. pylori VacA. Expressed SKD1^E235Q and PIKfyve^K1831E typically localize on the membranes that outline dilated endomembrane structures. SKD1^E235Q vesicles appear positive for markers of either the early or late endocytic compartments, whereas PIKfyve^K1831E predominantly co-localizes with MVB markers and not with markers for the earlier compartments (13-17). These observations suggest that the two mutants dilate both distinct and overlapping endocytic structures. The dramatic vacuolation induced by PIKfyve^K1831E is corrected by high levels of PIKfyve^WT or PtdIns-3,5-P₂, implying that PIKfyve-originated production of PtdIns-3,5-P₂ maintains mammalian cell morphology and endocytic membrane homeostasis (15, 16). The overall evolutionary conservation of the molecular events involved in endocytosis together with the conservation of SKD1 and PIKfyve cellular roles in yeast and mammals suggest that, like their yeast orthologs, mammalian SKD1 and PIKfyve may be functionally related. In this context we sought to examine, first, the functional relationship between the endocytic compartments defined by PIKfyve and SKD1 in mammalian cells and, second, to investigate the potential role of these enzymes in VacA-induced vacuolation. Our results suggest a functional connection between the two proteins, and indicate that PIKfyve, through PtdIns-3,5-P₂ production, but not SKD1, negatively regulates the VacA-induced endomembrane vacuolation.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

cDNA Constructs and Transient Cell Transfection-- Generation and characterization of pEGFP-SKD1^WT and pEGFP-SKD1^E235Q (16) or pCMV5-HA-PIKfyve^WT, pEGFP-HA-PIKfyve^WT, and pCMV5-HA-PIKfyve^K1831E were described previously (17-19). COS-7 cells, maintained as described previously (15), were seeded on 22 × 22-mm coverslips (35-mm dishes) and transfected with the cDNA constructs indicated in the figure legends using LipofectAMINE (Invitrogen) as a transfection reagent. Twenty-four hour posttransfection the cells were processed for fluorescence microscopy or further treated with activated VacA toxin.

Generation of Stable Cell Lines-- A stably transfected doxycycline-inducible (Tet-On) cell line inducibly expressing PIKfyve^WT was generated following the Tet-Off/Tet-On gene Expression Systems manual (Clontech). Briefly, PIKfyve_S^WT cDNA (released by XbaI-SalI from pBluescript IISK+ (19) together with an HA-encoding adapter (flanked with BamHI and XbaI restriction sites) were cloned into the BamHI-SalI site of the pTRE2hyg vector. The expected organization of the construct was confirmed by restriction mapping. The pTRE2hygHA-PIKfyve^WT vector, linearized by SalI, was used to transfect a parental HEK293 Tet-On cell line (Clontech) by LipofectAMINE as a transfection reagent. Transfected cells were selected by hygromycin treatment at 125 µg/ml, a concentration found to eliminate all susceptible cells after 5-7 days of treatment. Individual cell clonal lines were isolated by cloning cylinders, propagated, and then probed for a doxycycline-inducible expression of recombinant PIKfyve^WT by Western blotting with anti-HA polyclonal antibodies (a gift of Mike Czech) and immunofluorescence microscopy with anti-HA-monoclonal antibody (a gift of Steve Doxey).

VacA Toxin Purification, Activation, and Cell Treatment-- VacA purified from H. pylori 60190 culture supernatant was activated before use by a dropwise addition of 0.2 N HCl to pH 3 as described elsewhere (20). Cells were treated with the activated toxin (10 µg/ml final concentration) in the growing media supplemented with 20 mM HEPES, pH 7.4, and 5 mM NH₄Cl for a time interval indicated in the figure legends.

Fluorescence Microscopy-- HA-PIKfyve proteins were detected by indirect immunofluorescence microscopy using an anti-HA monoclonal antibody and Texas Red-conjugated goat anti-mouse secondary antibody. Cell fixation and washing conditions were described previously (17). EGFP-based proteins were detected by GFP signals. Fluorescence analyses were performed with a digital imaging fluorescent microscope (Nikon Eclipse TE200) using a 40× Hoffman Modulation Contrast objective or Nikon Apo DM 60/1.4 immersion lens as indicated in the figure legends. Visible vacuoles were assessed by the phase-contrast and the above objectives. Representative images were captured by a SPOT RT Slider charge coupled device camera (Diagnostic Instruments) and processed further by SPOT 3.2 software.

Cell Microinjection-- COS-7 cells, grown on coverslips, were transferred to a Leibowitz-15 medium and microinjected in the cytoplasm with a semiautomatic microinjector (Eppendorf micromanipulator 5171 and Femtojet 5247) as described previously (16). Briefly, cells were injected with the indicated PIs mixed with Texas Red-dextran (70,000, Molecular Probes) or with Texas Red-dextran alone and then returned to a complete medium to recover for 2 h at 37 °C. Cells were then treated overnight with VacA toxin and observed by fluorescence microscopy the following day. The presence or absence of visible vacuoles were assessed by phase-contrast microscopy. For data quantitation, the vacuolating effects of VacA in injected (dextran-positive) or non-injected cells within the same dish were calculated as percentage of the total number of counted cells (>100 cells/condition) in three independent experiments and are presented as mean ± S.E.

PIKfyve Lipid Kinase Activity-- To examine whether VacA had a direct effect on PIKfyve lipid kinase activity in vitro, PIKfyve immunoprecipitates were preincubated for 15 min at 37 °C with activated VacA (0.3-10 µg/ml final concentration), followed by subsequent analysis of the generated radiolabeled products, as described previously (18, 21).

SDS-PAGE and Immunoblotting-- Cell lysates were subjected to SDS-PAGE (6% gel), and after electrotransfer, the membrane was probed with anti-HA polyclonal antibodies as described previously (15, 21).

Quantitation of VacA-induced Vacuolation by Neutral Red-- Twenty-four hours following induction of protein expression in HEK293 stable (PIKfyve^WT, clone 9) or parental clones in the presence or absence of doxycycline, cells seeded on 12-well plates were left untreated or treated with VacA for 5 h (triplicates/condition). The cells were then allowed to take up neutral red for 4 min as described previously (22). Following washings, neutral red was extracted from cells with acidified alcohol. The absorbance (540 nm) of the samples was measured with a spectrophotometer (Beckman DU-50). The net neutral red accumulation was calculated by subtracting the absorbance of non-treated cells from the values of the VacA-treated samples.

	RESULTS AND DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

We have previously observed that expression of enzymatically defective, dominant-negative mutants of PIKfyve and SKD1 in cells of kidney origin induce similar endomembrane vacuolation. The mutant proteins were found to populate related endocytic compartments as defined by the mannose 6-phosphate receptor marker (14-16). Fig. 1 illustrates typical images of the abnormal phenotypes in COS-7 cells transiently expressing SKD1^E235Q or PIKfyve^K1831E, where multiple enlarged vesicles and endomembrane vacuoles could be readily observed. To examine a possible functional relationship between these two proteins we co-expressed SKD1 and PIKfyve wild type proteins and/or their dominant-negative mutants in COS-7 cells. Co-expression of SKD1^WT and PIKfyve^WT did not change the typical localization pattern seen previously with the singly expressed proteins (14-17). Thus, pEGFP-SKD1^WT showed the characteristic diffuse cytosolic and nuclear localization and co-expressed PIKfyve^WT displayed the typical extranuclear scattered puncta on a background of a diffuse cytosolic signal (Fig. 2, a and b). No noticeable morphological alterations were found in cells co-expressing the wild types (Fig. 2c). However, co-expression of ATPase-deficient SKD1^E235Q and PIKfyve^WT resulted in several changes in protein localization as well as in cell morphology. Thus, in the presence of PIKfyve^WT, the SKD1^E235Q-positive structures appeared as fine perinuclear puncta (Fig. 2d). This differed drastically from the SKD1^E235Q-positive dilated vesicles and vacuoles observed previously by the singly expressed SKD1^E235Q in cells of kidney origin and confirmed here (Refs. 13 and 14 and Fig. 1, a and b). The PIKfyve^WT-positive compartment also underwent a significant redistribution in the presence of co-expressed SKD1^E235Q and was seen as perinuclear clusters, rather than scattered puncta (Fig. 2e). In contrast to this PIKfyve^WT-dependent inhibition of the SKD1^E235Q-induced abnormal morphology, SKD1^WT did not prevent the abnormal phenotype produced by dominant-negative PIKfyve^K1831E. As demonstrated in Fig. 2, g-i, cells co-expressing SKD^WT and PIKfyve^K1831E produced a vacuolation similar to that observed upon expression of PIKfyve^K1831E alone. Finally, the vacuolation in cells co-expressing the two dominant-negative mutants appeared as a sum of their individual abnormal phenotypes with only partial co-localization of the two proteins upon merging the images (Fig. 2, j-l, and not shown). These observations are consistent with the notion that expressed SKD1^E235Q and PIKfyve^K1831E dilate both overlapping and distinct populations of endocytic structures, which are functionally related. The fact that increased PIKfyve enzymatic activity could largely overcome the action of the ATPase-deficient SKD1 mutant, but not vice versa, indicates that the functions of the two proteins are not interchangeable. Rather, we speculate the two enzymes act on endosomal membranes in sequential fashion whereby the SKD1 ATPase activity most likely precedes PIKfyve action and appears important for the organization of the endocytic membranes defined by PIKfyve.

View larger version (96K): [in this window] [in a new window]   Fig. 1.   Expression of SKD1E235Q in COS-7 cells induces abnormal phenotype resembling that induced by PIKfyveK1831E expression. COS-7 cells were transfected with pEGFP-SKD1E235Q (a and b) or pCMV5-HA-PIKfyveK1831E cDNAs (c and d). Twenty-four hours posttransfection the cells were fixed and processed for immunofluorescence microscopy with anti-HA antibodies as described under "Experimental Procedures." Expression of PIKfyveK1831E was detected by Texas Red-conjugated anti-mouse IgG (c) and that of SKD1E235Q by the fluorescence signals of GFP (a). Phase-contrast images of the same fields (b and d) show the abnormal morphology. Note that vacuoles due to SKD1E235Q appear at both lower (arrowheads in a) and high expression levels (arrows in a). The same holds true for PIKfyveK1831E expression as shown earlier (15). Bar, 10 µm.

View larger version (93K): [in this window] [in a new window]   Fig. 2.   Expression of PIKfyveWT attenuates the abnormal morphology induced by SKD1E235Q. COS-7 cells were co-transfected with pEGFP-SKD1 and pCMV5-HA-PIKfyve cDNAs encoding the wild type or mutant proteins paired in the indicated combinations. Twenty-four hours posttransfection the cells were fixed and processed for immunofluorescence microscopy with anti-HA antibodies as described under "Experimental Procedures." Expression of the PIKfyve proteins was detected by Texas Red-conjugated anti-mouse IgG (b, e, h, and k), that of SKD1 by the fluorescence signals of GFP (a, d, g, and j), and the vacuolation phenotype, by phase-contrast of the same fields (c, f, i, and l). Arrows in d-f demonstrate lack of a vacuolation phenotype in SKD1E235Q/PIKfyveWT co-expressing cell, and arrowheads indicate the presence of a vacuolation phenotype in a cell expressing only SKD1E235Q. Bar, 10 µm.

The endomembrane vacuolation induced by the dominant-negative ATPase-deficient SKD1 or kinase-deficient PIKfyve, presented in Fig. 1, morphologically resembles the intracellular vacuolation caused by the H. pylori VacA toxin. Accumulated experimental evidence supports two hypotheses for the molecular mechanism of VacA action: the toxin forms anion-selective channels and/or interacts with protein targets that trigger the endogenous vacuolating mechanism (reviewed in Ref. 1). In this regard endosomal proteins, such as SKD1 and PIKfyve, whose dominant-interfering mutants mimic VacA vacuolation should be a central focus, since they are likely candidate down-stream targets of the VacA toxin. Therefore, we examined the effect of SKD1^WT and PIKfyve^WT expression on VacA-induced vacuolation. For this purpose transfected COS-7 cells were treated for 24 h with VacA and the number of the SKD1^WT- or PIKfyve^WT-expressing cells that displayed a vacuolated phenotype was assessed. As illustrated in Fig. 3A, expression of PIKfyve^WT, but not SKD1^WT, markedly inhibited the vacuolation induced by VacA. Quantitation of results from four separate experiments demonstrated that only 7 ± 1% of the PIKfyve^WT-expressing cells developed vacuoles upon VacA treatment versus 60 ± 5% of the non-transfected cells in the same dish (Fig. 3B). Under the same conditions VacA induced vacuolation in 58 ± 6% of the SKD1^WT-transfected cells (Fig. 3B). The potential role for PIKfyve in VacA-induced vacuolation was further supported by the detection of expressed EGFP-PIKfyve^WT on the limiting membrane of VacA-induced vacuoles in cells where, occasionally, the abnormal phenotype failed to be corrected (not shown).

View larger version (49K): [in this window] [in a new window]   Fig. 3.   Expression of PIKfyveWT, but not SKD1WT, prevents H. pylori VacA-induced vacuolation. COS-7 cells were transfected with the indicated pEGFP-based constructs and intoxicated with VacA as specified under "Experimental Procedures." The cells were fixed 24 h after VacA addition and observed by fluorescence (a and c) and phase-contrast microscopy of the same fields (b and d). A, shown are cells expressing SKD1WT (panel a) that display large perinuclear vacuoles similar to those of the non-transfected cells (panel b), a PIKfyveWT-expressing cell (panel c) that failed to be vacuolated by VacA, in contrast to the neighboring cells (panel d). Bar, 10 µm. B, quantitation of vacuolating effects of VacA from four independent experiments assessed by appearance of visible vacuoles through phase-contrast microscopy. The number of vacuole-positive cells is expressed as percentage of the total number of counted cells (>100 cells/condition/experiments) and presented as mean ± S.E.

To confirm the observed inhibition of VacA-induced vacuolation by PIKfyve^WT in another cell system and to provide alternative quantification of this phenomenon, we examined the vacuolating effect of VacA in a HEK293 stable line inducibly expressing PIKfyve^WT. These cells express ~7-8-fold higher levels of PIKfyve^WT versus the endogenous protein 24 h after induction of the protein expression with doxycycline as revealed by Western blotting analysis with anti-PIKfyve antibodies (Fig. 4A). The expressed protein seems, at least in part, to localize to the authentic PIKfyve sites as judged by its vesicular appearance, along with the cytosolic staining upon immunofluorescence microscopy analysis with an anti-HA antibody (Fig. 4B). Importantly, induction of the PIKfyve^WT expression resulted in a substantial inhibition of the cellular vacuolation due to VacA as revealed on the basis of neutral red uptake of the vacuolated cells (Fig. 4C). Thus, 5 h following intoxication with VacA, HEK293 cells that were induced to express PIKfyve^WT showed 60% less net neutral red uptake versus non-induced cells (Fig. 4C). Importantly, doxycycline treatment did not affect the basal or VacA-dependent neutral red uptake in the parental HEK293 cells (Fig. 4C). It should be noted that at the level of expression of PIKfyve^WT in this cell type, 24 h following VacA treatment, both induced and non-induced cells were vacuolated and showed similar values of the neutral red uptake (not shown). However, expression of PIKfyve^WT in this cell type not only substantially inhibited early VacA induced vacuolation but also led to a faster recovery of cell morphology back to normal after removal of VacA. As seen on the images presented in Fig. 4D, 18 h following the toxin removal, HEK293 cells induced to express PIKfyve^WT showed practically no vacuoles. In contrast, the non-induced cells displayed prominent vacuolation (Fig. 4D). Together, these results demonstrate that while dominant-negative mutants of SKD1 and PIKfyve could both induce a vacuolated phenotype, only high levels of PIKfyve^WT inhibit the vacuole formation due to VacA. These observations suggest that VacA-dependent vacuoles arise in a process that is negatively regulated by PIKfyve. SKD1 action is likely upstream or distal to the site of VacA action on endocytic membranes.

View larger version (36K): [in this window] [in a new window]   Fig. 4.   Induction of PIKfyveWT expression in HEK293 stable cell line inhibits VacA induced vacuolation. HEK293 parental (Control) or stable cell lines inducibly expressing HA-PIKfyveWT (clone 9) were incubated in the presence (+) or absence () of doxycycline for 18 h to induce protein expression as indicated. A, cell lysates of clone 9 were obtained in RIPA buffer supplemented with protease inhibitors and subjected to SDS-PAGE and immunoblotting with anti-PIKfyve antibodies as described under "Experimental Procedures." Shown is a chemiluminescence detection of a representative immunoblot. B, cells (clone 9) were fixed and processed for immunofluorescence microscopy with anti-HA antibody as described under "Experimental Procedures." C, cells were treated with VacA for 5 h and then incubated for 4 min with neutral red. The dye was extracted and the absorbance (540 nm) of the samples determined (1:10 dilution). Shown is the mean ± S.E. of the increase in the optical density over corresponding non-treated control cells from three independent experiments in triplicates. The optical density measured at the basal conditions was between 0.053 and 0.110 and was subtracted to calculate the net neutral red uptake (see "Experimental Procedures"). D, cells (clone 9) were treated with VacA for 24 h and the medium was then replaced with growth medium. Cells were observed live 18 h after VacA withdrawal by phase-contrast microscopy. Shown are random fields of induced or non-induced cells as indicated. Absence of vacuoles due to VacA in PIKfyveWT-induced cells is apparent. Bar, 10 µm.

Having established that high levels of PIKfyve negatively regulate the VacA-induced endomembrane defects, we next examined whether this effect is mediated by the PIKfyve lipid product PtdIns-3,5-P₂. This is particularly important, since PIKfyve produces several different products (PtdIns-3,5-P₂, produces PtdIns-5-P and phosphoprotein(s); Refs. 16, 18, 21, and 23), each of which might contribute to the ability of PIKfyve^WT to inhibit VacA-induced vacuole formation. Therefore, we next examined whether increased cellular levels of PtdIns3,5-P₂ could selectively inhibit the VacA-induced vacuolation in COS cells. As shown in Fig. 5, microinjection of PtdIns-3,5-P₂, but not PtdIns-4,5-P₂ or PtdIns-5-P (not shown), inhibited the capacity of VacA to induce cell vacuolation. Quantitation from three independent microinjection experiments indicate that only 15 ± 2% of the PtdIns-3,5-P₂-injected cells exhibited vacuoles, notably with a less pronounced appearance compared with the PtdIns-4,5-P₂-injected or non-injected cells, in which the VacA efficiency was 60 ± 5% (p < 0.001). Thus, similarly to the vacuolation induced by the kinase-defective dominant-negative PIKfyve mutants (16), the VacA-induced vacuolation was selectively rescued by increased PtdIns-3,5-P₂ levels.

View larger version (98K): [in this window] [in a new window]   Fig. 5.   Microinjected PtdIns-3,5-P2 selectively prevents VacA-induced vacuolation. COS-7 cells were microinjected in the cytosol with mixtures of Texas Red-dextran and the indicated PIs and then treated with VacA toxin as described under "Experimental Procedures." Twenty-four hours after VacA treatment the cells were fixed for fluorescence microscopy. Shown are fluorescence images (a and c) visualizing the microinjected cells by Texas Red-dextran signals and the phase-contrast images of the same fields (b and d). Depicted are two PtdIns-3,5-P2- (arrows in b) and three PtdIns-4,5-P2-injected cells (arrowheads in d) demonstrating practically no vacuole formation (b) or prominent vacuolation (d), respectively, due to VacA. Bar, 10 µm.

The dramatic inhibition of VacA-induced vacuolation by two independent approaches, i.e. expression of PIKfyve^WT in different cell types and cytosolic microinjection of PtdIns-3,5-P₂, demonstrated above, strongly supports the central role of PIKfyve and its lipid product PtdIns-3,5-P₂ in the molecular mechanisms of endomembrane vacuolation induced by VacA. However, VacA does not directly inhibit PIKfyve, because, when added to the in vitro PIKfyve kinase assay, the toxin did not inhibit PtdIns-3,5-P₂ production (not shown). This result is consistent with the notion that VacA exerts an indirect inhibitory effect on this enzyme. Determination of the intracellular PtdIns-3,5-P₂ levels in response to VacA as well as the predicted upstream intermediate of the PIKfyve pathway that is negatively regulated by VacA, are important objectives for future studies.

Thus far, three proteins, each localized on late endosomal-lysosomal membranes and displaying the ability to bind and hydrolize GTP, have been shown to be important in VacA-induced vacuole formation, i.e. Rab7 (4), Rac1 (5), and dynamin (6). Interestingly, these GTPases affect similarly the VacA action in that the expression of the dominant-negative mutants inhibits the formation of vacuoles, whereas expression of the wild type proteins or constitutively active mutants either has no effect or slightly augments the effect of the toxin (4-6). These results are consistent with a hypothesis that VacA intoxication is associated with an intracellular increase of the active forms of Rac1, Rab7, or dynamin. The fact that none of the constitutively active mutants, by themselves, are able to mimic VacA suggests, however, additional mechanisms. In contrast to the action of GTPases, PIKfyve was able both to inhibit VacA-induced vacuolation upon increasing the cellular levels of its enzymatic activity or generated product and to mimic VacA vacuolation upon expression of enzymatically inactive dominant-negative mutants. These data suggest that VacA-dependent indirect inhibition of PIKfyve lipid kinase activity and reduced PtdIns-3,5-P₂ production could potentially be the sole triggering mechanism involved in the toxin-induced vacuolation. Whether and how Rac1, Rab7, and dynamin are involved in the endogenous vacuolation initiated by the PtdIns-3,5-P₂ depletion remain to be identified.

In conclusion, we demonstrate here that unlike SKD1, PIKfyve, through its PtdIns-3,5-P₂ producing activity, inhibits the vacuolation induced by the H. pylori VacA toxin. Among the candidate molecular intermediates, reported previously (4-6) and here, only dominant-negative PIKfyve could mimic VacA endomembrane vacuolation, thus making PIKfyve undoubtedly a very interesting VacA target for future clinical and fundamental studies.

	FOOTNOTES

^* This work was supported by National Institute of Health Grants DK58058 (to A. S.) and DK53623 (to T. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Physiology, Wayne State University School of Medicine, 540 E. Canfield, Detroit, MI 48201. Tel.: 313-577-5674; Fax: 313-577-5494; E-mail: ashishev@med.wayne.edu.

Published, JBC Papers in Press, September 3, 2002, DOI 10.1074/jbc.M208068200

	ABBREVIATIONS

The abbreviations used are: MVB, multivesicular body; PI, phosphoinositide; PtdIns, phosphatidylinositol; P, phosphate; P₂, bisphosphate; GFP, green fluorescent protein; EGFP, enhanced green fluorescent protein; HA, hemagglutinin; WT, wild type.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. H. Brumell and M. A. Scidmore Manipulation of Rab GTPase Function by Intracellular Bacterial Pathogens Microbiol. Mol. Biol. Rev., December 1, 2007; 71(4): 636 - 652. [Abstract] [Full Text] [PDF]

				M. Yamamoto, M. Z. Chen, Y.-J. Wang, H.-Q. Sun, Y. Wei, M. Martinez, and H. L. Yin Hypertonic Stress Increases Phosphatidylinositol 4,5-Bisphosphate Levels by Activating PIP5KIbeta J. Biol. Chem., October 27, 2006; 281(43): 32630 - 32638. [Abstract] [Full Text] [PDF]

				O. C. Ikonomov, D. Sbrissa, and A. Shisheva Localized PtdIns 3,5-P2 synthesis to regulate early endosome dynamics and fusion Am J Physiol Cell Physiol, August 1, 2006; 291(2): C393 - C404. [Abstract] [Full Text] [PDF]

				D. Sbrissa, O. C. Ikonomov, J. Strakova, R. Dondapati, K. Mlak, R. Deeb, R. Silver, and A. Shisheva A Mammalian Ortholog of Saccharomyces cerevisiae Vac14 That Associates with and Up-Regulates PIKfyve Phosphoinositide 5-Kinase Activity Mol. Cell. Biol., December 1, 2004; 24(23): 10437 - 10447. [Abstract] [Full Text] [PDF]

				D. Sbrissa, O. C. Ikonomov, J. Strakova, and A. Shisheva Role for a Novel Signaling Intermediate, Phosphatidylinositol 5-Phosphate, in Insulin-Regulated F-Actin Stress Fiber Breakdown and GLUT4 Translocation Endocrinology, November 1, 2004; 145(11): 4853 - 4865. [Abstract] [Full Text] [PDF]

				K. Tsujita, T. Itoh, T. Ijuin, A. Yamamoto, A. Shisheva, J. Laporte, and T. Takenawa Myotubularin Regulates the Function of the Late Endosome through the GRAM Domain-Phosphatidylinositol 3,5-Bisphosphate Interaction J. Biol. Chem., April 2, 2004; 279(14): 13817 - 13824. [Abstract] [Full Text] [PDF]

				Y. Li, A. Wandinger-Ness, J. R. Goldenring, and T. L. Cover Clustering and Redistribution of Late Endocytic Compartments in Response to Helicobacter pylori Vacuolating Toxin Mol. Biol. Cell, April 1, 2004; 15(4): 1946 - 1959. [Abstract] [Full Text] [PDF]

				O. C. Ikonomov, D. Sbrissa, M. Foti, J.-L. Carpentier, and A. Shisheva PIKfyve Controls Fluid Phase Endocytosis but Not Recycling/Degradation of Endocytosed Receptors or Sorting of Procathepsin D by Regulating Multivesicular Body Morphogenesis Mol. Biol. Cell, November 1, 2003; 14(11): 4581 - 4591. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 277/48/46785    most recent M208068200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ikonomov, O. C. Articles by Shisheva, A. Search for Related Content PubMed PubMed Citation Articles by Ikonomov, O. C. Articles by Shisheva, A. Social Bookmarking                      What's this?